SARS-COV-2 IMMUNOASSAY METHOD AND IMMUNOASSAY KIT, AND MONOCLONAL ANTIBODY OR ANTIBODY FRAGMENT THEREOF

The present invention provides a SARS-CoV-2 immunoassay method comprising a step for contacting a biological sample with a monoclonal antibody or an antibody fragment thereof, said monoclonal antibody binding to the nucleocapsid protein of SARS-CoV-2, wherein the monoclonal antibody or an antibody f...

Full description

Saved in:
Bibliographic Details
Main Authors YAJI, SHOHEI, UNO, SATORU, OCHIAI, YASUSHI, KOHNO, KEIGO, ASAI, TOMOHIDE, HIROTA, JIRO, HEWSON, CHRISTOPHER KENTA
Format Patent
LanguageEnglish
French
Published 22.12.2022
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:The present invention provides a SARS-CoV-2 immunoassay method comprising a step for contacting a biological sample with a monoclonal antibody or an antibody fragment thereof, said monoclonal antibody binding to the nucleocapsid protein of SARS-CoV-2, wherein the monoclonal antibody or an antibody fragment thereof binds to SARS-CoV-2 having been treated with serine protease. La présente invention concerne un procédé de dosage immunologique du SARS-CoV-2 comprenant une étape de mise en contact d'un échantillon biologique avec un anticorps monoclonal ou un fragment d'anticorps associé, ledit anticorps monoclonal se liant à la protéine de nucléocapside du SARS-CoV-2, l'anticorps monoclonal ou un fragment d'anticorps associé se liant au SARS-CoV-2 ayant été traité avec de la sérine protéase.
Bibliography:Application Number: CA20223218421